Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced Breast Cancer|Chemotherapy Effect
Interventions: DRUG: inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences